AINDEX
Markets

Bruker Corporation (BRKR)

BRKRNASDAQ-GSBiotechnology: Laboratory Analytical Instruments

$61.59

+1.26 (+2.09%) today

Closed, Nov 13, 4:00 PM ET

+2.09% 1D
Market cap
$9.41bn
P/E
31.6
EPS, last 4 quarters
$1.95
Dividend yield
0.33%
Day range
–
52-week range
$32.37 to $68.98
Average volume
–
Previous close
$60.33

Analysts

9 covering

Hold3 buy, 5 hold, 1 sell

Targets a year out average $66.00, +7.2% from here

$55.00now $61.59$85.00

Earnings

next estimate $0.7600

Next report

Dec 2025

-9.2%

Mar 2026

+34.8%

Jun 2026

+28.9%

Sep 2026

+33.3%

estimate reported, and the surprise

Financials

QuarterDec 2025Mar 2026Jun 2026Sep 2026
Revenue$977.20m$823.40m$838.50m$874.00m
Gross profit$449.20m$379.80m$416.00m$429.30m
Operating income$76.30m$10.20m-$65.30m-$91.00m
Net income$26.00m$14.40m-$52.00m-$111.80m

Last four quarters: revenue $3.51bn, margin -3.5%, free cash flow $244.70m

News

8 latest

The company

Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels.

Sector
Industrials
Industry
Biotechnology: Laboratory Analytical Instruments
Exchange
NASDAQ-GS
Region
North America
Website
bruker.com

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.